We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Notice for Artesunate (Amivas Australia Pty Ltd)
Active ingredients
Artesunate
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
powder and diluent for injection
Indication
Initial treatment of severe malaria for adults and children
Therapeutic area
Infectious diseases